These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2650583)

  • 41. Quinapril versus atenolol in the treatment of mild to moderate essential hypertension.
    Bahena JH; Estrella ME; Muñoz M
    Clin Ther; 1992; 14(4):527-36. PubMed ID: 1525787
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Benefit and risk evaluation of quinapril hydrochloride.
    Barkhordarian M; Lawrence JA; Ulusan S; Erbay MI; Aronow WS; Gupta R
    Expert Opin Drug Saf; 2023 Apr; 22(4):271-277. PubMed ID: 37060355
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quinapril hydrochloride effects on renal function in patients with renal dysfunction and hypertension: a drug-withdrawal study.
    Miller MA; Texter M; Gmerek A; Robbins J; Shurzinske L; Canter D
    Cardiovasc Drugs Ther; 1994 Apr; 8(2):271-5. PubMed ID: 7918140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ACE inhibitors in the elderly.
    Posvar EL; Sedman AJ
    Angiology; 1991 May; 42(5):387-96. PubMed ID: 2035890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Life-threatening postoperative angioedema following treatment with an angiotensin converting enzyme inhibitor].
    Maier C
    Anaesthesist; 1995 Dec; 44(12):875-9. PubMed ID: 8594963
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Conversion from oral ACE inhibitor to intravenous quinaprilat administration in mild to moderate essential hypertension].
    Schmidt BM; Smilde J; Oldenbroek C; Wehling M
    Med Klin (Munich); 1998 Dec; 93(12):701-6. PubMed ID: 10024837
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative pharmacokinetics of captopril, enalapril, and quinapril.
    Vertes V; Haynie R
    Am J Cardiol; 1992 Apr; 69(10):8C-16C. PubMed ID: 1546641
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Düsseldorf, Munich, Germany.
    Nussberger J; Fleck E; Bahrmann H; Delius W; Schultheiss HP; Brunner HR
    Eur Heart J; 1994 Dec; 15 Suppl D():113-22. PubMed ID: 7713100
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessing the clinical need for short-term conversion from oral to parenteral angiotensin converting enzyme inhibitor therapy in hypertensive patients. A quinapril to quinaprilat placebo-controlled model.
    Whelton A; McCormick L; Wombolt D; Goldstein R; Canter D
    Eur Heart J; 1997 Jan; 18(1):140-7. PubMed ID: 9049526
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of heart failure in dogs with ACe inhibitors: comparison of quinapril and captopril].
    Morisse B; Kersten U
    Tierarztl Prax; 1995 Oct; 23(5):489-96. PubMed ID: 8585063
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The rapidity of drug dose escalation influences blood pressure response and adverse effects burden in patients with hypertension: the Quinapril Titration Interval Management Evaluation (ATIME) Study. ATIME Research Group.
    Flack JM; Yunis C; Preisser J; Holmes CB; Mensah G; McLean B; Saunders E
    Arch Intern Med; 2000 Jun; 160(12):1842-7. PubMed ID: 10871979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preliminary hemodynamic report of the efficacy and safety of quinapril in acute and chronic treatment of patients with congestive heart failure.
    Banas JS
    Angiology; 1989 Apr; 40(4 Pt 2):396-404. PubMed ID: 2705644
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quinapril versus enalapril in the treatment of mild-to-moderate essential hypertension.
    Sánchez S; Luna A; Orozco R; Velasco G
    Clin Ther; 1991; 13(5):651-5. PubMed ID: 1799922
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of quinapril on functional status of elderly patients with diastolic heart failure.
    Zi M; Carmichael N; Lye M
    Cardiovasc Drugs Ther; 2003 Mar; 17(2):133-9. PubMed ID: 12975595
    [TBL] [Abstract][Full Text] [Related]  

  • 56. What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors?
    Francis GS; Gassler JP
    Cleve Clin J Med; 2001 Mar; 68(3):185-6. PubMed ID: 11263844
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia.
    Oosterga M; Voors AA; Pinto YM; Buikema H; Grandjean JG; Kingma JH; Crijns HJ; van Gilst WH
    Am J Cardiol; 2001 Mar; 87(5):542-6. PubMed ID: 11230836
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ACE inhibitors in the treatment of hypertension in the older patient.
    Canter D; Frank G
    Eur Heart J; 1990 May; 11 Suppl D():33-43. PubMed ID: 2193809
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients.
    Kontopoulos AG; Athyros VG; Papageorgiou AA; Skeberis VM; Basayiannis EC; Boudoulas H
    Coron Artery Dis; 1997; 8(8-9):517-24. PubMed ID: 9431480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quinapril for hypertension.
    Med Lett Drugs Ther; 1992 Mar; 34(866):27-8. PubMed ID: 1542279
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.